We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CBIH market cap is 6.6M. The company's latest EPS is USD -0.0001 and P/E is 0.00.
| Year End 31 May 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 297k | 506k | 214k | 317k | 249k |
| Operating Income | -112k | -481k | -875k | -738k | -486k |
| Net Income | -92k | -446k | -872k | -1.03M | -651k |
| Year End 31 May 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 127k | 50k | 113k | 43k | 57k |
| Total Liabilities | 190k | 311k | 473k | 634k | 1.14M |
| Total Equity | -63k | -261k | -360k | -591k | -1.08M |
| Year End 31 May 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -99k | -487k | -870k | -913k | -480k |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 139k | 400k | 861k | 890k | 471k |
| Market Cap | 6.6M |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 10.56B |
| Average Volume (1 week) | 1.23M |
| Average Volume (1 Month) | 1.78M |
| 52 Week Change | -30.56% |
| 52 Week High | 0.002 |
| 52 Week Low | 0.0004 |
| Spread (Intraday) | 0 (14.29%) |
| Company Name | Cannabis Bioscience International Holdings Inc (PK) |
| Address |
7700 e arapahoe road centennial, colorado 80112 1268 |
| Website | https://www.chnc-hdh.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
